Bond Laboratories 2-for-1 Forward Stock Split Declared Effective

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Assd W & D Maxs	LSE:BNDB	London	Ordinary Share	GB00B04S5N76	ORD 25P(ASSD WHAMPTON & DUDLEY MAX SHS)

Share Name

Share Symbol

Market

Type

Share ISIN

Share Description

Assd W & D Maxs

LSE:BNDB

London

Ordinary Share

GB00B04S5N76

ORD 25P(ASSD WHAMPTON & DUDLEY MAX SHS)

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

0.00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Industry Sector

Turnover

Profit

EPS - Basic

PE Ratio

Market Cap

N/A

Bond Laboratories 2-for-1 Forward Stock Split Declared Effective

09/01/2008 3:07pm

PR Newswire (US)

Assd W & D Maxs (LSE:BNDB)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Assd W & D Maxs Charts.

SOLANA BEACH, Calif., Jan. 9 /PRNewswire-FirstCall/ -- Bond Laboratories, Inc. (OTC:BNDB) (BULLETIN BOARD: BNDB) , a publicly held company, today announced that the previously declared 2-for-1 forward split of its common stock, which will be in the form of a 100% stock dividend, has been declared effective by the NASD. Shareholders will be entitled to receive one additional share for each share held. The new shares will be distributed via mail or electronically on or after January 8, 2008 to the record holders of the Company's common stock as of the close of business (EST) on January 8, 2008. The shares are expected to begin trading on a post-split basis January 9,2008. Bond Laboratories post-split shares will trade under the new symbol: BNLB. "The previously announced board's action conveys its confidence in the long-term prospects for Bond," said Eric Schick, President of Bond Laboratories. "Additionally, we hope that the increased number of shares that will be outstanding will further improve the liquidity of the Company's stock in the marketplace." About Bond Laboratories: Bond Laboratories, Inc. manufactures and markets branded nutritional products in the United States. It focuses on developing proprietary products and delivery platforms principally in energy, pain relief, and weight loss categories. The company is commercializing Fusion energy products consisting of Fusion, Fusion Blast, and Fusion Shot, as well as Migratol 24/7. Its energy products contain vitamins, amino acids, and enzymes. The company was founded in 2005 and is headquartered in Solana Beach, California. Safe Harbor Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Contact: Scott Landow Phone: 858.847.9000 Fax: 858.847.9090 DATASOURCE: Bond Laboratories, Inc. CONTACT: Scott Landow of Bond Laboratories, Inc., +1-858-847-9000, Fax, +1-858-847-9090,

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

BNDB Assd W & D Maxs